Kara Franzen, DPM
Foot & Ankle Surgery · Dubuque, IANPI 1780068114
Payments from drug & device makers
What this record shows
Stryker accounts for 73.8% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $1,554 and has fallen 89.8% since, to $158 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in IA, where the typical reported total is $2,625.
Across 58 payments — averaging $41.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Organogenesis Inc.$189
- Zimmer Biomet$97
- Prism Medical$91
- Integra Lifesciences Corporation$36
- Smith+Nephew$31
- plus $183 from 11 others
What the payments were for
- Travel & lodging$1,14548%
- Food & beverage$1,24452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 24 | $1,764 |
| Organogenesis Inc. | 12 | $189 |
| Zimmer Biomet | 5 | $97 |
| Prism Medical | 1 | $91 |
| Integra Lifesciences Corporation | 2 | $36 |
| Smith+Nephew | 2 | $31 |
| Tactile Systems Technology Inc | 2 | $25 |
| Convatec Inc. | 1 | $25 |
| Axogen | 1 | $18 |
| Bioventus LLC | 1 | $16 |
| Medline Industries LP | 1 | $16 |
| Averitas Pharma Inc. | 1 | $15 |
| Biotissue Holdings Inc. | 1 | $14 |
| Kerecis Limited | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Davol Inc. | 1 | $14 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,390 in reported general payments places this provider in the 45th percentile of 112 foot & ankle surgery providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 39 | $304 |
| Mupirocin | 15 | $146 |
| Cephalexin | 17 | $75 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Dubuque
- Jason KepplerDubuque$3K
- Nicole JedlickaDubuque$3K
- Michael LeeDes Moines$2.1M
- Phinit PhisitkulSioux City$1.4M
- Sean GrambartDes Moines$590K
- Kelsey MillonigDes Moines$330K
- Charles CibulaCedar Falls$38K
- Gregory FooteWaterloo$35K
- Nathan ShumwayCouncil Bluffs$33K
- Justin RaatzDes Moines$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.